Bare nitinol stent enabled recanalization of long-segment, chronic total occlusion of superficial femoral and adjacent proximal popliteal artery in diabetic patients presenting with critical limb ischemia

Cardiovascular Revascularization Medicine

Volumn 11, Issue 4, 2010, Pages 232-235

  Taneja, Manish ^a   Tay, Kiang Hiong ^a   Dewan, Atul ^a   Sebastian, Mathew G ^a   Pasupathy, Shanker ^a   Lin, Sheuh En ^a   Teo, Terence ^a   Lo, Richard ^a   Tan, Seck Guan ^a   Irani, Farah G ^a   Tan, Bien Soo ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Diabetes mellitus; Self expanding nitinol stents; Superficial femoral artery

Indexed keywords

NITINOL;

ABOVE KNEE AMPUTATION; ADULT; AGED; ARTERIOVENOUS FISTULA; ARTERY EMBOLISM; ARTICLE; BARE METAL STENT; BELOW KNEE AMPUTATION; DIABETES MELLITUS; FEMALE; FOLLOW UP; FOOT AMPUTATION; GANGRENE; HUMAN; LEG PAIN; LEG ULCER; LIMB ISCHEMIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; PRIORITY JOURNAL; RECANALIZATION; SUPERFICIAL FEMORAL ARTERY;

AGED; ALLOYS; AMPUTATION; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; CHRONIC DISEASE; CONSTRICTION, PATHOLOGIC; CRITICAL ILLNESS; DIABETIC ANGIOPATHIES; FEMALE; FEMORAL ARTERY; HUMANS; ISCHEMIA; LIMB SALVAGE; LOWER EXTREMITY; MALE; MIDDLE AGED; POPLITEAL ARTERY; PROSTHESIS DESIGN; REGISTRIES; RETROSPECTIVE STUDIES; SINGAPORE; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 77957748523     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2009.10.002     Document Type: Article

References (20)

1. Selvin E, Erlinger TP Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004, 110:738-743.
2. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease, detection, awareness, and treatment in primary care. JAMA 2001, 286:1317-1324.
3. Becker GJ, et al. The importance of increasing public and physician awareness of peripheral arterial disease. J Vasc Interv Radiol 2002, 13:7-11.
4. Yeo TC, Chan YH, Low LP, Venketasubramanian N, Lim SC, Tay JC, et al. Risk factor profile and treatment patterns of patients with atherothrombosis in Singapore: insight from the REACH Registry. Ann Acad Med Sing 2008, 37:365-371.
5. Criqui MH, et al. Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease: an analysis of risk factors. Am J Epidemiol 1989, 129:1110-1119.
6. Akbari CM, LoGerfo FW Diabetes and peripheral vascular disease. J Vasc Surg 1999, 30:373-384.
7. Gelev S, Spasovski G, Dzikova S, Trajkovski Z, Damjanovski G, Amitov V, et al. Vascular calcification and atherosclerosis in hemodialysis patients: what can we learn from the routine clinical practice?. Int Urol Nephrol 2008, 40(3):763-770.
8. Wanner C Prevention of cardiovascular disease in chronic kidney disease patients. Semin Nephrol 2009, 29:24-29.
9. Dormandy JA, Rutherford RB Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000, 31:S1-S296.
10. Peng CW, Tan SG Perioperative and rehabilitative outcomes after amputation for ischemic leg gangrene. Ann Acad Med Sing 2000, 29:168-172.
11. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004, 141:421-431.
12. Norgren L, Hiatt WR, et al. TASC II section A on risk factors in PAD. TASC II 2007. Page 7.
13. Menzoian JO, LaMorte WW, Paniszyn CC, McBride KJ, Sidawy AN, LoGerfo FW, et al. Symptomatology and anatomic patterns of peripheral vascular disease: differing impact of smoking and diabetes. Ann Vasc Surg 1989, 3:324-328.
14. Sheetz MJ, King GL Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002, 228:2579-2588.
15. Klinkert P, Post PN, Breslau PJ, van Bockel JH Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 2004, 27:357-362.
16. Dosluoglu HH, Cherr GS, Lall P, Harris LM, Dryjski ML Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease. J Vasc Surg 2008, 48:1166-1174.
17. Surowiec SM, Davies MG, Eberly SW, Rhodes JM, Illig KA, Shortell CK, Lee DE, Waldman DL, Green RM Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 2005, 41:269-278.
18. Sabeti S, Mlekusch W, Amighi J, Minar E, Schillinger M Primary patency og long-segment self expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther 2005, 12:6-12.
19. Bakken AM, Palchik E, Hart JP, Rhodes JM, Saad WE, Davies MG Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions. J Vasc Surg 2007, 46:946-958.
20. Vogel TR, Shindelman LE, Nackman GB, Graham AM Efficacious use of nitinol stents in the femoral and popliteal arteries. J Vasc Surg 2003, 38:1178-1184.